Company Filing History:
Years Active: 1991-1998
Title: Mark E Poulton: Innovator in Parasiticidal Compounds
Introduction
Mark E Poulton is a notable inventor based in Tadworth, GB. He has made significant contributions to the field of parasiticidal compounds, holding a total of 3 patents. His work focuses on developing innovative solutions for combating parasitic infections.
Latest Patents
Poulton's latest patents include the development of parasiticidal milbemycin derivatives. These compounds are characterized by specific formulas, wherein R.sup.1 is hydrogen or methyl, R.sup.2 is hydrogen or (E)-2-methyl 2-butenoyloxy, and R.sup.3 is hydrogen or hydroxy. The compounds have demonstrated anthelmintic utility and are obtainable through the fermentation of Streptomyces E225 NCIB 12310 or Streptomyces E225B NCIB 12509. The process for producing these derivatives also emphasizes their antihelminthic properties.
Career Highlights
Throughout his career, Mark E Poulton has worked with prominent companies such as Pfizer Corporation and Beecham Group Plc. His experience in these organizations has contributed to his expertise in the field of pharmaceuticals and parasiticidal research.
Collaborations
Poulton has collaborated with notable coworkers, including Geoffrey H Baker and Roderick J Dorgan. These partnerships have likely enhanced his research and development efforts in creating effective parasiticidal compounds.
Conclusion
Mark E Poulton's innovative work in the field of parasiticidal compounds showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to finding effective solutions for parasitic infections.